Page 2 - World Effectiveness News Today

/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that 13 abstracts will be presented at the American Society of Hematology (ASH) Annual...

Multiple presentations will highlight the clinical utility of ZYNLONTA (loncastuximab tesirine-lpyl) in DLBCL and Cami (camidanlumab tesirine) in Hodgkin lymphoma ADC Therapeutics SA (NYSE: ADCT)

Key data includes results for intravenous administration of Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) in Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Patients DUBLIN

First presentation of RSV Older Adult vaccine candidates pivotal phase III efficacy and safety data New data showing Shingrix... | October 12, 2022

SUMMIT, N.J., Sept. 26, 2022 /PRNewswire/ -- CSL Seqirus, a business of CSL Limited (ASX:CSL), today announced new data from four real-world studi...

-- AbbVie to present 30 abstracts demonstrating its leadership in neuroscience, including continued migraine treatment research across the spectru...

/PRNewswire/ -- Endo International plc (NASDAQ:ENDP) announced today that data from clinical and non-clinical studies of Endo Aesthetics Qwo® (collagenase...

/PRNewswire/ -- DaVita Clinical Research (DCR) will present eight research abstracts from company representatives and medical professionals during the American...

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data demonstrating robust prostate-specific antigen (PSA)...

Endos Qwo (collagenase clostridium histolyticum-aaes) Data to Be Presented at The Aesthetic Meeting 2021 DUBLIN, April 29, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that data relevant to the use of Endo Aesthetics Qwo (collagenase clostridium histolyticum-aaes), which received FDA approval in July 2020 for the treatment of moderate to severe cellulite in the buttocks of adult women, will be presented during The Aesthetic Meeting 2021. This data will be highligh...